Skip to content

Onconetix, Inc.

ONCO

CIK 0001782107

← back to feed
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$23.92M
+76.1% YoY Q1 May 2026
EPS Diluted (TTM)
−$244.97
+99.1% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$13.79M
Q1 May 2026
Cash
$25.75M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
11.46M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings